New therapeutic targets in multiple myeloma.
Gahrton
Gösta
G
Department of Medicine, Karolinska Institute, Huddinge Hospital, S 141 86 Huddinge, Sweden. Gosta.Gahrton@medhs.ki.se
D001713:Biphenyl Compounds / Q000627:therapeutic use; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy*; D019098:Telomerase / Q000037:antagonists & inhibitors
D001713:Biphenyl Compounds; C492719:p38alpha inhibitor CMPD1; D019098:Telomerase